Last data update: Jun 16, 2021. (Total: 3330 publications since 2011)
|Query Trace: all>>Wei Xing[CDC Author]|
| Cost-effectiveness of implementing 13-valent pneumococcal conjugate vaccine for U.S. adults aged 19 years and older with underlying conditions.
Miwako Kobayashi, Charles Stoecker, Wei Xing, Bo-Hyun Cho, and Tamara Pilishvili
Human vaccines & immunotherapeutics 2021 Jan 1-9
Similar articles in PubMed DOI:10.1080/21645515.2020.1861876